Loading quotes...
Forecast
| Buy |
Â
2 |
| Hold |
Â
3 |
| Sell |
Â
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | 44.46m | 4,135.47% |
| EBITDA | 49.41m | 4,563.31% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | âŹ35.1m |
Number of shares | 26.63m |
52-week high/low | âŹ89.46 - âŹ1.00 |
| Dividends | No |
Beta | 0.16 |
P/E ratio | 0.06 |
PEG ratio | 0.00 |
P/B ratio | 1.18 |
P/S ratio | 0.78 |
Company profile
| Name | NovaBay Pharmaceuticals Inc |
| CEO | Michael Kazley |
| Employees | 13 |
